Ovid Therapeutics (1OT.F) Q4 2025 Earnings

12NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.15
-0.12
-0.09
-0.05

Details

Expected EPS
-0.12930374
Actual EPS
-0.14664200000000002
Surprise EPS
-0.02
Surprise Percent
+13.41%

Description

Ovid Therapeutics (1OT.F) has reported earnings of -0.14664200000000002 per share for Q4 2025.

0 Comments

Share your thoughts